Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial
1. 系统已在2026-05-01 11:49:21对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.2337/dc22-0490
其他信息:
出版社: American Diabetes Association
作者: Melissa-Rosina Pasqua; Adnan Jafar; Alessandra Kobayati; Michael A. Tsoukas; Ahmad Haidar
全文下载地址: https://diabetesjournals.org/care/article-pdf/46/1/165/694875/dc220490.pdf

